APIs

Bromocriptine Mesylate

Bromocriptine mesylate is a semisynthetic ergot alkaloid derivative with potent dopaminergic activity. It is indicated for the management of signs and symptoms of Parkinsonian Syndrome. Bromocriptine also inhibits prolactin secretion and may be used to treat dysfunctions associated with hyperprolactinemia. It also causes sustained suppression of somatotropin (growth hormone) secretion in some patients with acromegaly. Bromocriptine has been associated with pulmonary fibrosis....
Products Inquiry

Description

Product Name:   Bromocriptine Mesylate 
Synonyms:   2-Bromo-alpha-ergocryptine methanesulfonate; BCT;
(+)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',
6'-18-trione methanesulfonate salt
Description   White or off white crystal powder, afraid of light
Cas No.:   22260-51-1 
Molecular Formula:   C33H44BrN5O8S
Molecular Weight:   750.7
Assay:   99%
Standard   USP
Usage:   Bromocriptine mesylate an ergoline derivative, is a dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease (PD), hyperprolactinaemia, neuroleptic malignant syndrome, and type 2 diabetes.